Company · CIK 0001365216 · SIC 2834 — Pharmaceutical Preparations
Sucampo Pharmaceuticals, Inc. · SCMP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2015 MForm 4 → | Jul 22, 4:58 pm EDT | Thomas J KnappOther | 64,528 | $12.38 | $798,714 | 12,718 | — | plan? |
| Jun 30, 2015 AForm 4 → | Nov 20, 4:09 pm EST | Stanley G MieleChief Commercial Officer | 93 | $13.88 | $1,291 | 93 | — | plan? late |
| Jun 30, 2015 AForm 4 → | Nov 20, 4:08 pm EST | Matthias AlderEVP, Business Dev. & Licensing | 936 | $13.88 | $12,989 | 936 | — | plan? late |
| Jun 30, 2015 AForm 4 → | Nov 20, 4:05 pm EST | Matthew Maxwell DonleyExec. V.P., Human Resources | 468 | $13.88 | $6,495 | 468 | — | plan? late |
| Mar 31, 2015 SForm 4 → | Apr 2, 5:58 pm EDT | Sachiko Kuno10% Owner | 1,600,000 | $14.00 | $22,400,000 | 20,274,689 | −7.31% | plan? |
| Mar 31, 2015 SForm 4 → | Apr 2, 5:51 pm EDT | S&R Technology Holdings, LLC10% Owner | 1,186,113 | $14.00 | $16,605,582 | 20,274,689 | −5.53% | plan? |
| Mar 31, 2015 SForm 4 → | Apr 2, 5:49 pm EDT | Ryuji Ueno10% Owner | 1,600,000 | $14.00 | $22,400,000 | 20,274,689 | −7.31% | plan? |
| Mar 11, 2015 SForm 4 → | Mar 18, 9:38 pm EDT | Anthony C. CelesteDirector | 65,966 | $17.34 | $1,143,850 | 0 | −100% | plan? late |
| Mar 11, 2015 MForm 4 → | Mar 18, 9:38 pm EDT | Anthony C. CelesteDirector | 65,966 | $7.29 | $480,942 | 16,666 | — | plan? late |
| Mar 11, 2015 SForm 4 → | Mar 18, 9:37 pm EDT | William AshtonDirector | 129,766 | $17.42 | $2,260,372 | 0 | −100% | plan? late |
| Mar 11, 2015 MForm 4 → | Mar 18, 9:37 pm EDT | William AshtonDirector | 129,766 | $5.88 | $762,700 | 16,666 | — | plan? late |
| Dec 29, 2014 GForm 5 → | Feb 13, 2015, 5:38 pm EST | Ryuji Ueno10% Owner | 1,000,000 | — | — | 21,460,802 | — | plan? |
| Dec 29, 2014 GForm 5 → | Feb 13, 2015, 5:36 pm EST | Sachiko Kuno10% Owner | 1,000,000 | — | — | 21,460,802 | — | plan? |
| Dec 29, 2014 GForm 5 → | Feb 13, 2015, 5:25 pm EST | S&R Technology Holdings, LLC10% Owner | 1,000,000 | — | — | 21,460,802 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2018 DForm 4 → | Feb 13, 4:59 pm EST | Maureen OconnellDirector | 100,000 | $9.08 | $908,300 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:59 pm EST | Timothy P WalbertDirector | 10,000 | $7.70 | $77,000 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:57 pm EST | Robert J. SpiegelDirector | 60,000 | $3.85 | $231,200 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:56 pm EST | Karen L. SmithDirector | 30,000 | $7.05 | $211,500 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:54 pm EST | Paul R EdickDirector | 10,000 | $7.70 | $77,000 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:54 pm EST | Matthew Maxwell DonleyEVP, Global HR, IT & Strategy | 379,000 | $7.64 | $2,896,440 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:54 pm EST | Peter GreenleafChief Executive Officer | 1,667,000 | $7.21 | $12,015,350 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:52 pm EST | John JohnsonDirector | 60,000 | $3.91 | $234,800 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:51 pm EST | Peter A KienerChief Science Officer | 508,703 | $7.32 | $3,724,133 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:48 pm EST | Peter LichtlenChief Medical Officer | 314,400 | $8.92 | $2,803,312 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:47 pm EST | Peter P. PfreundschuhCFO | 150,000 | $7.10 | $1,065,000 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:44 pm EST | Jones W. BryanSr. Vice Pres., BD & Licensing | 150,000 | $7.10 | $1,065,000 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:41 pm EST | Jason Patrick MeyenburgChief Commercial Officer | 150,000 | $7.35 | $1,102,500 | 0 | — | |
| Feb 13, 2018 DForm 4 → | Feb 13, 4:41 pm EST | Alex DriggsGeneral Counsel & Corp. Sec. | 60,818 | $3.61 | $219,674 | 0 | — | |
| Dec 7, 2017 MForm 4 → | Dec 11, 5:30 pm EST | Peter A KienerChief Science Officer | 50,000 | — | — | 242,567 | — | |
| Jun 1, 2017 AForm 4/A → | Jul 7, 4:55 pm EDT | Paul R EdickDirector | 10,000 | — | — | 10,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 5, 9:59 pm EDT | Paul R EdickDirector | 10,000 | — | — | 10,000 | — | amended |
| Jun 1, 2017 AForm 4 → | Jun 5, 9:57 pm EDT | Timothy P WalbertDirector | 10,000 | — | — | 40,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 5, 9:56 pm EDT | Robert J. SpiegelDirector | 10,000 | — | — | 60,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 5, 9:56 pm EDT | Maureen OconnellDirector | 10,000 | — | — | 100,000 | — | |
| Jun 1, 2017 AForm 4 → | Jun 5, 9:55 pm EDT | John JohnsonDirector | 10,000 | — | — | 60,000 | — | |
| Mar 20, 2017 AForm 4 → | Mar 22, 4:02 pm EDT | Peter P. PfreundschuhCFO | 150,000 | — | — | 150,000 | — | |
| Mar 6, 2017 AForm 4 → | Mar 8, 5:03 pm EST | Peter LichtlenChief Medical Officer | 45,000 | — | — | 314,400 | — | |
| Mar 6, 2017 AForm 4 → | Mar 8, 5:02 pm EST | Peter A KienerChief Scientific Officer | 133,000 | — | — | 626,270 | — | |
| Mar 6, 2017 AForm 4 → | Mar 8, 5:02 pm EST | Peter GreenleafChief Executive Officer | 237,000 | — | — | 1,667,000 | — | |
| Mar 6, 2017 AForm 4 → | Mar 8, 5:01 pm EST | Matthew Maxwell DonleyEVP, Human Resources | 101,000 | — | — | 379,000 | — | |
| Mar 6, 2017 AForm 4 → | Mar 8, 5:01 pm EST | Matthias AlderEVP, Bus.Dev.&Lic., GC & Sec | 63,000 | — | — | 325,500 | — | |
| Nov 28, 2016 MForm 4 → | Nov 30, 4:01 pm EST | Peter GreenleafCEO | 200,000 | — | — | 1,430,000 | — | |
| Nov 28, 2016 MForm 4 → | Nov 30, 4:01 pm EST | Daniel P GetmanDirector | 20,000 | — | — | 60,000 | — | |
| Nov 23, 2016 MForm 4 → | Nov 28, 9:30 pm EST | Matthias AlderEVP, Bus. Dev.&Lic, G.C. &Sec. | 150,000 | — | — | 262,500 | — | |
| Mar 2, 2016 AForm 4 → | Mar 4, 5:56 pm EST | Peter GreenleafChief Executive Officer | 420,000 | — | — | 1,630,000 | — | |
| Mar 2, 2016 AForm 4 → | Mar 4, 5:47 pm EST | Andrew P SmithChief Financial Officer | 57,000 | — | — | 215,600 | — | |
| Mar 2, 2016 AForm 4 → | Mar 4, 5:45 pm EST | Peter LichtlenChief Medical Officer | 44,000 | — | — | 269,400 | — | |
| Mar 2, 2016 AForm 4 → | Mar 4, 5:44 pm EST | Matthew Maxwell DonleyExec. V.P., Human Resources | 75,000 | — | — | 278,000 | — | |
| Mar 2, 2016 AForm 4 → | Mar 4, 5:42 pm EST | Peter A KienerChief Scientific Officer | 116,270 | — | — | 493,270 | — | |
| Mar 2, 2016 AForm 4 → | Mar 4, 5:40 pm EST | Matthias AlderEVP, Business Dev. & Licensing | 62,500 | — | — | 412,500 | — | |
| Oct 12, 2015 AForm 4 → | Oct 14, 4:03 pm EDT | Timothy P WalbertDirector | 30,000 | — | — | 30,000 | — | |
| Jul 20, 2015 MForm 4 → | Jul 22, 4:58 pm EDT | Thomas J KnappOther | 64,528 | — | — | 216,122 | — | |
| May 29, 2015 AForm 4 → | Jun 2, 5:45 pm EDT | Kei S TolliverDirector | 20,000 | — | — | 82,000 | — | |
| May 29, 2015 AForm 4 → | Jun 2, 5:44 pm EDT | Robert J. SpiegelDirector | 20,000 | — | — | 50,000 | — | |
| May 29, 2015 AForm 4 → | Jun 2, 5:43 pm EDT | Maureen OconnellDirector | 20,000 | — | — | 90,000 | — | |
| May 29, 2015 AForm 4 → | Jun 2, 5:42 pm EDT | Barbara A MunderDirector | 20,000 | — | — | 90,000 | — | |
| May 29, 2015 AForm 4 → | Jun 2, 5:39 pm EDT | John JohnsonDirector | 20,000 | — | — | 50,000 | — | |
| May 29, 2015 AForm 4 → | Jun 2, 5:38 pm EDT | Daniel P GetmanDirector | 20,000 | — | — | 110,000 | — | |
| Mar 11, 2015 MForm 4 → | Mar 18, 9:38 pm EDT | Anthony C. CelesteDirector | 65,966 | — | — | 10,234 | — | late |
| Mar 11, 2015 MForm 4 → | Mar 18, 9:37 pm EDT | William AshtonDirector | 129,766 | — | — | 10,234 | — | late |
| Mar 4, 2015 AForm 4 → | Nov 20, 4:05 pm EST | Matthias AlderEVP, Business Dev. & Licensing | 50,000 | — | — | 350,000 | — | late |
| Mar 4, 2015 AForm 4 → | Mar 16, 11:52 am EDT | Matthew Maxwell DonleyExec. V.P., Human Resources | 28,000 | — | — | 203,000 | — | late |
| Mar 4, 2015 AForm 4 → | Mar 16, 11:51 am EDT | Peter LichtlenChief Medical Officer | 44,000 | — | — | 225,400 | — | late |
| Mar 4, 2015 AForm 4 → | Mar 13, 8:52 pm EDT | Peter A KienerChief Scientific Officer | 77,000 | — | — | 377,000 | — | late |
| Mar 4, 2015 AForm 4 → | Mar 13, 8:28 pm EDT | Stanley G MielePresident | 21,000 | — | — | 219,400 | — | late |
| Mar 4, 2015 AForm 4 → | Mar 13, 8:25 pm EDT | Peter GreenleafChief Executive Officer | 210,000 | — | — | 1,210,000 | — | late |
| Mar 4, 2015 AForm 4 → | Mar 13, 8:24 pm EDT | Andrew P SmithChief Financial Officer | 22,000 | — | — | 158,600 | — | late |
| Mar 4, 2015 AForm 4 → | Mar 12, 12:33 pm EDT | Knapp Thomas J c/o Sucampo Pharmaceuticals, Inc.EVP, Chief Legal Ofc, Corp Sec | 45,000 | — | — | 280,650 | — | late |
| Jan 30, 2015 AForm 4 → | Feb 4, 6:57 pm EST | Andrew P SmithChief Financial Officer | 50,000 | — | — | 136,600 | — | late |
| Jan 16, 2015 AForm 4 → | Jan 26, 6:04 pm EST | Robert J. SpiegelDirector | 30,000 | — | — | 30,000 | — | late |
| Sep 1, 2011 MForm 4 → | Aug 31, 2015, 4:57 pm EDT | Daniel P GetmanDirector | 30,000 | — | — | 80,000 | — | late |